Sagimet Biosciences (SGMT) Q2 2024 Earnings
SGMT·Reported August 14, 2024·Before market open
Diluted EPS came in at $-0.25, beat the $-0.34 consensus by $0.09.
Diluted EPS
$-0.25beat by $0.09
Consensus: $-0.34
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Sagimet Biosciences's Q2 2024 earnings report.
Sagimet Biosciences (SGMT) reported Q2 2024 earnings on August 14, 2024 before market open.
Sagimet Biosciences reported diluted EPS of $-0.25 for Q2 2024.
EPS beat the consensus estimate of $-0.34 by $0.09.
You can read the 10-Q periodic report (0001558370-24-012136) directly on SEC EDGAR. The filing index links above go to sec.gov.